A randomized, phase 3, double-blind trial examining methotrexate and etanercept as monotherapy or in combinstion for treating psoriatic arthritis: A comparison of the composite measures used to evaluate disease activity

অনুরূপ উপাদানগুলি

• Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis
  অনুযায়ী: Coates, L, অন্যান্য
  প্রকাশিত: (2020)
• Design and rationale of the Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects with Psoriatic Arthritis (SEAM-PsA)
  অনুযায়ী: Mease, P, অন্যান্য
  প্রকাশিত: (2018)
• Methotrexate in psoriasis and psoriatic arthritis
  অনুযায়ী: Coates, L, অন্যান্য
  প্রকাশিত: (2020)
• Impact of clinical domains other than arthritis on composite outcomes in psoriatic arthritis: comparison of treatment effects in the SEAM-PsA trial
  অনুযায়ী: Helliwell, PS, অন্যান্য
  প্রকাশিত: (2022)
• Tofacitinib as monotherapy following methotrexate withdrawal in patients with psoriatic arthritis previously treated with open-label tofacitinib plus methotrexate: a randomised, placebo-controlled substudy of OPAL Balance
  অনুযায়ী: Nash, P, অন্যান্য
  প্রকাশিত: (2020)